Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: November 1, 1999
Last updated: February 8, 2013
Last verified: April 2001
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: January 2004 (Final data collection date for primary outcome measure)